Loading...
Harrow Health, Inc. 8.625% Senior Notes due 2026
HROWL•NASDAQ
HealthcareMedical - Pharmaceuticals
$25.20
$-0.10(-0.40%)
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Quarterly Earnings Reports & Financial Results
Analyze Harrow Health, Inc. 8.625% Senior Notes due 2026’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Harrow Health, Inc. 8.625% Senior Notes due 2026’s actual vs. estimated earnings across recent quarters.
No data available
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Quarterly Earnings Details
Detailed breakdown of Harrow Health, Inc. 8.625% Senior Notes due 2026’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.